Frontage Holdings (HKSE:01521) Days Sales Outstanding : 69.97 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Frontage Holdings Days Sales Outstanding?

Frontage Holdings's average Accounts Receivable for the six months ended in Dec. 2023 was HK$394 Mil. Frontage Holdings's Revenue for the six months ended in Dec. 2023 was HK$1,027 Mil. Hence, Frontage Holdings's Days Sales Outstanding for the six months ended in Dec. 2023 was 69.97.

The historical rank and industry rank for Frontage Holdings's Days Sales Outstanding or its related term are showing as below:

HKSE:01521' s Days Sales Outstanding Range Over the Past 10 Years
Min: 45.67 Med: 56.22 Max: 68.73
Current: 68.73

During the past 8 years, Frontage Holdings's highest Days Sales Outstanding was 68.73. The lowest was 45.67. And the median was 56.22.

HKSE:01521's Days Sales Outstanding is ranked better than
52.36% of 888 companies
in the Biotechnology industry
Industry Median: 72.545 vs HKSE:01521: 68.73

Frontage Holdings's Days Sales Outstanding increased from Dec. 2022 (60.11) to Dec. 2023 (69.97).

Frontage Holdings Days Sales Outstanding Historical Data

The historical data trend for Frontage Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frontage Holdings Days Sales Outstanding Chart

Frontage Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

56.68

56.84

55.57

58.44

68.49

Frontage Holdings Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial									58.82	56.39	60.11	67.82	69.97

Competitive Comparison of Frontage Holdings's Days Sales Outstanding

For the Biotechnology subindustry, Frontage Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Frontage Holdings's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Frontage Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Frontage Holdings's Days Sales Outstanding falls into.

Frontage Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Frontage Holdings's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (360.651	+	400.932)	/	2 )	/	2029.416	*	365
=	380.7915					/	2029.416	*	365
=	68.49

Frontage Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (386.566	+	400.932)	/	2 )	/	1026.981	*	365 / 2
=	393.749					/	1026.981	*	365 / 2
=	69.97

Frontage Holdings (HKSE:01521) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Frontage Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Frontage Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Frontage Holdings (HKSE:01521) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Frontage Holdings Corp (HKSE:01521) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

FGHQF:USA

Address

700 Pennsylvania Drive, Exton, PA, USA, 19341

Website

https://www.frontagelab.com

Frontage Holdings Corp is a contract research organization providing integrated, scientifically driven research, analytical and development services. Geographically the group operates in both PRC and North America. The services provided in the North American segment, include Bioanalytical, CMC, DMPK and Safety and Toxicology services in the USA and Canada. The service offered in PRC includes Bioanalytical, Bioequivalence and CMC services in the PRC. Further, it also provides bioanalytical services, which are offered throughout the drug discovery and development process both in the United States and China.

Executives

Hang Zhou Tai Ge Yi Yao Ke Ji Gu Fen You Xian Gong Si	2101 Beneficial owner
Li Song	2101 Beneficial owner
Kabouter Management Llc	2102 Investment manager
Hangzhou Tigermed Consulting Co., Ltd.
Hongkong Tigermed Co., Limited

Frontage Holdings (HKSE:01521) Headlines

No Headlines